Xeris Biopharma: Chief legal officer Beth Hecht sold 16,666 shares

What happened

• The filing says Beth Hecht, chief legal officer and corporate secretary, sold 16,666 shares in an open-market sale on Oct 1, 2026. The filing reports a weighted average sale price of $9.41 for total proceeds of $156,792.

Key details

• Transaction date and price: Oct 1, 2026 — open-market sale of 16,666 shares at a weighted average price of $9.41; prices ranged from $9.180 to $9.680 (F2).
• Transaction code: S (sale).
• Shares owned after the transaction: not reported in the filing.
• Footnotes: F1 — the transaction was effected pursuant to a Rule 10b5-1 trading plan adopted Aug 8, 2025; F2 — price is a weighted average and the reporting person will provide a breakdown on request.
• Filing date: filed on Oct 2, 2026.

Why it may matter

• The filing shows this was a market sale executed under a Rule 10b5-1 trading plan, not an options exercise or a gift.
• The filing does not show why the insider traded or why the company acted.